Home

Results 11 - 20 of 12,949 for injected. Search took 4.099 seconds.  
Sort by date/Sort by relevance
UNICEF price data for vaccines and injection supplies are publicly available, but data on delivery costs have until recently been less accessible. (...) Table 3: Assumed injection device parameter values Parameter Value Injection syringes Unit price of BCG injection syringe (2020 US$) 0.036 Unit price of 0.5 ml injection syringe (2020 US$) 0.037 Injection syringe wastage 5% Reconstitution syringes Unit price of reconstitution syringe (2020 US$) 0.042 Reconstitution syringe wastage 5% Safety boxes Unit price of safety box (5 liters) 0.557 Capacity of safety box (no. of syringes) 100 Freight and handling fees Injection device freight charge 30% Injection device UNICEF handling fee 8% 7 Delivery costs Delivery costs, also referred to as operational costs, are defined as costs associated with delivering vaccines exclusive of vaccine costs (Box 1). (...) Costs of vaccine and injection supplies for a child less than 12 months amounts to US$25.
Language:English
Score: 981617.3 - https://www.unicef.org/romania...%20a%20Child%20-%20english.pdf
Data Source: un
Select language Select language English South-East Asia India Home Health topics Our work News Emergencies About us Home / News / Detail / Punjab first state to introduce injection safety programme Punjab first state to introduce injection safety programme 10 August 2017 Highlights At the World Hepatitis Day 2017 event, organized by the Department of Health and Family Welfare, Government of Punjab, the state Action Plan on Injection Safety was launched by Mr Brahm Mohindra, Health Minister, Government of Punjab at Chandigarh on 28 July 2017. (...) This State Action Plan details key activities to be jointly undertaken by WHO Country Office for India and Government of Punjab as part of WHO’s Injection safety Implementation Project in state of Punjab. The injection safety project aims to support policy process for adoption of re-use prevention (RUP) syringes in therapeutic care in both, public and private sector; increase awareness about rational use of injections, capacity building of healthcare providers, improve health care waste management practices and step-up overall attention on the quality and safety of healthcare.
Language:English
Score: 977005.1 - https://www.who.int/india/news...uce-injection-safety-programme
Data Source: un
Methods This was a prospective non-randomized community intervention trial designed to test the provision of injectable contraceptives by community-based reproductive health agents (CBRHAs). (...) In addition, clients of CBRHAs were less likely to discontinue using injectable contraceptives over three injection cycles than health post clients. Conclusion Receiving injectable contraceptives from CBRHAs proved as safe and acceptable to this sample of Ethiopian women as receiving them in health posts from HEWs.
Language:English
Score: 975616.3 - https://www.who.int/bulletin/volumes/89/8/11-086710-ab/en/
Data Source: un
In Vietnam and Iran, some 50 – 60% of AIDS cases are among injecting drug users and in Russia the figures rise to over 80%. (...) “Scaling up treatment among injecting drug users is essential to fight HIV and to help stop discrimination among this vulnerable group. (...) Where injecting drug use is a criminal offence, as is the case in many countries, drug users have even more limited or no access to prevention and treatment services.
Language:English
Score: 975616.3 - https://www.who.int/3by5/newsitem8/en/
Data Source: un
Methods This was a prospective non-randomized community intervention trial designed to test the provision of injectable contraceptives by community-based reproductive health agents (CBRHAs). (...) The outcomes observed when injectable contraceptives were administered by HEWs in health posts and when they were administered by CBRHAs were compared. This was a prospective non-randomized community intervention trial designed to test the provision of injectable contraceptives by community-based reproductive health agents (CBRHAs).
Language:English
Score: 974463.2 - https://www.who.int/reproducti...mily_planning/bulletin89_8/en/
Data Source: un
When used properly, injections save lives. But, many developing countries face barriers. (...) In 2004, 417 000 people died a result of diseases spread through unsafe injection practices. 1 Expanding injection use to family planning, maternal, newborn and child health services would be possible if these problems could be overcome. (...) “Does a novel prefilled injection device make postpartum oxytocin easier to administer?
Language:English
Score: 972872.3 - https://www.who.int/pmnch/abou...m/2010_showcase/en/index4.html
Data Source: un
Factors associated with willingness to pay for methadone maintenance treatment (MMT) among HIV-infected Vietnamese patients, by injection drug use (IDU) status html, 8kb Discussion This study assessed willingness to pay for MMT among patients with HIV infection in three Vietnamese epicentres of injection-drug-driven HIV infection. (...) This is the first study to report the costs of injection drug use among HIV-infected individuals in Viet Nam. (...) Finally, injection drug users who experienced other types of drug rehabilitation before taking MMT were more willing to pay for treatment and willing to pay a much greater amount than injection drug users with no history of drug rehabilitation.
Language:English
Score: 963865.3 - https://www.who.int/bulletin/volumes/91/7/12-115147/en/
Data Source: un
Injectable Polio Vaccine (IPV): Flyer | UNICEF Uganda Skip to main content Uganda Toggle navigation Global Links Visit UNICEF Global High contrast Uganda Explore UNICEF Who we are UNICEF in Uganda Our representative Work with us Press centre Donate Main navigation What we do Research and reports Stories Take action Search area has closed. (...) Search Close Search UNICEF Fulltext search Max Report Injectable Polio Vaccine (IPV): Flyer What parents and caregivers need to know UNICEF Uganda/2012/Ramson Highlights The Booklet contains information on the new Injectable Polio Vaccine (IPV). Author Ministry of Health, UNICEF, World Health Organisation Publication date April 2017 Languages English Download Download file (PDF, 860,17 KB) Related topics Polio Uganda More to explore Report Injectable Polio Vaccine (IPV): Fact sheet What you need to know See the full report Report Injectable Polio Vaccine (IPV): Booklet What parents and caregivers need to know See the full report Report Question and Answer booklet on routine immunization Learn more about immunization See the full report Report Measles: Question and Answer Booklet for leaders What leaders need to know and do See the full report Footer UNICEF Home What we do Research and reports Stories Take action About us Press centre UNICEF in Uganda Our representative Work with us Procurement Become a donor Social Footer Secondary Contact Legal Footer tertiary Report fraud, abuse, wrongdoing
Language:English
Score: 961590.1 - https://www.unicef.org/uganda/...ctable-polio-vaccine-ipv-flyer
Data Source: un
Know the risks WHO is alerting people to the risks of contracting hepatitis from unsafe blood, unsafe injections, and sharing drug-injection equipment. Some 11 million people who inject drugs have hepatitis B or C infection. (...) Eliminating unnecessary injections is also an effective strategy to protect against hepatitis transmission. There are 16 billion injections administered every year. Around 5% of these injections are for immunization, a further 5% for procedures like blood transfusions and injectable contraceptives, and the remaining 90% to administer medicines.
Language:English
Score: 960153.5 - https://www.who.int/news/item/...rgent-action-to-curb-hepatitis
Data Source: un
OPENING DATE COMMODITY VALUE IN USD AWARDED COMPANY PURPOSE RFP-DAN-2017-502502 Clinical Laboratory Supplies Time Bound LTA Fleischhacker GmbH & Co.KG 12 months + 12 months RFP-DAN-2017-502502 Clinical Laboratory Supplies Time Bound LTA IMRES BV 12 months + 12 months RFP-DAN-2017-502502 Clinical Laboratory Supplies Time Bound LTA Amex Export Import GmbH 12 months + 12 months RFP-DAN-2017-502502 Clinical Laboratory Supplies Time Bound LTA VWR International GmbH 12 months + 12 months RFP-DAN-2019-503099 30.10.2019 Pneumococcal conjugate vaccines 5,597,510.00 Pfizer Inc 2021 to 2025 NA NA Procurement of BiPAP Machine for Afghanistan Country Office 617,499.69 World Health Organization (WHO) RFP-DAN-2020-503239 09.11.2020 Southern Hemisphere Seasonal Influenza Vaccine 2021 174,000.00 Green Cross Corporation RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Hindustan Syringes & Medical Devices Ltd. 01.01.2020 to 31.12.2021 RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Amson Vaccines & Pharma (Pvt.) Ltd. 01.01.2020 to 31.12.2022 RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Anhui Tiankang Medical Technology C 01.01.2020 to 31.12.2022 RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value BD International 01.01.2020 to 31.12.2022 RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value KD Medical GmbH Hospital Products 01.01.2020 to 31.12.2022 RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Sanavita Pharmaceuticals GmbH 11.08.2020 to 31.12.2022 RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Smurfit Kappa Sverige AB 01.01.2020 to 31.12.2022 RFP-DAN-2019-502979 05.08.2019 Safe Injection Equipment Target Value Pa Hu Oy 01.08.2020 to 31.12.2022 RFP-DAN-2018-502908 18.12.2018 Freeze-preventive Cold Boxes and Vaccine Carriers Time Bound LTA AOV INTERNATIONAL LLP 24 months + 12 months RFP-DAN-2018-502908 18.12.2018 Freeze-preventive Cold Boxes and Vaccine Carriers Time Bound LTA Qingdao LEFF International Trading Co., Ltd 24 months + 12 months RFP-DAN-2018-502908 18.12.2018 Freeze-preventive Cold Boxes and Vaccine Carriers Time Bound LTA 24 months + 12 months RFP-DAN-2018-502908 18.12.2018 Freeze-preventive Cold Boxes and Vaccine Carriers Time Bound LTA M S NILKAMAL LIMITED 31.08.2021 with possible extension by 12 months RFP-DAN-2020-503209 25.11.2020 COVID19 Vaccine Time Bound LTA AstraZeneca, AB Sweden 12 months + 12 months RFP-DAN-2020-503209 25.11.2020 COVID19 Vaccine Time Bound LTA Sinovac Biotech Co., Ltd. 12 months + 12 months RFP-DAN-2020-503209 25.11.2020 COVID19 Vaccine Time Bound LTA Janssen Pharmaceutica NV 12 months + 12 months RFP-DAN-2020-503209 25.11.2020 COVID19 Vaccine Time Bound LTA Moderna Switzerland GmbH 12 months + 12 months RFP-DAN-2017-502553 15.09.2017 Meningococcal ACW polysaccharide vaccine 1,876,081.87 Instituto de Tecnologia em Imunobiologicos Bio Manguinhos 31/12/2021 RFP-DAN-2020-503217 01.10.2020 Yellow Fever Vaccine 49,955,000.00 FSBSI "Chumakov FSC R&D IBP RAS" LTA – 12 months i.e. until 31-12-2021 RFP-DAN-2020-503217 01.10.2020 Yellow Fever Vaccine 4,380,000.00 Institut Pasteur de Dakar LTA – 12 months i.e. until 31-12-2021 RFP-DAN-2020-503217 01.10.2020 Yellow Fever Vaccine 7,680,000.00 Instituto de Tecnologia em Imunobiologicos Bio Manguinhos LTA – 12 months i.e. until 31-12-2021 RFP-DAN-2015-501985 13.04.2015 Oral Cholera Vaccine 38,778,000.00 EuBiologics Co Ltd additional 12 months i.e. until 31-12-2021 RFP-DAN-2015-501985 13.04.2015 Oral Cholera Vaccine 11,100,000.00 Sanofi Healthcare India Private Ltd additional 12 months i.e. until 31-12-2021
Language:English
Score: 958757.8 - https://www.unicef.org/supply/...20Contract-awards-Jan-2021.pdf
Data Source: un